Published on in CHOP News
Luminaries from Children’s Hospital of Philadelphia (CHOP) celebrated a unique opportunity to participate in “Reaching the Last Mile” event hosted by His Highness Sheikh Mohammed Bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, in partnership with The Bill and Melinda Gates Foundation, in Abu Dhabi, United Arab Emirates (UAE).
Published on in CHOP News
CHOP, a global leader in pediatric healthcare, exhibited some of its leading medical breakthroughs at the annual Arab Health Exhibition and Congress in Dubai.
Published on in Cancer Connections, International Update
Thanks to a recent initiative at CHOP, patients newly diagnosed with B-cell and T-cell ALL, and lymphoblastic lymphoma, now go home on average 9 days after diagnosis — that's 3 weeks sooner than previous stays.
Published on in CHOP News
CHOP and the United Arab Emirates entered into a Medical Services Agreement to provide expert medical care for children in the UAE, formally documenting their long-standing alliance.
Published on in CHOP News
Dr. Kassa Darge appeared on Doc Talk to discuss his career, mentors and global health work.
Published on in CHOP News, International Update
Physicians who see patients with mitochondrial disease have a practical new tool: the first published care standards to guide clinical care.
Published on in CHOP News, International Update
The Visiting Consultants Program will bring the expertise of CHOP physicians to patients at MOHAP hospitals within the United Arab Emirates.
Published on in CHOP News, International Update
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
Published on in International Update
CHOP created a professional development opportunity for nurses to visit international pediatric facilities, and meet the clinical staff caring for patients.
Published on in Cancer Connections, International Update
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than 170 patients in clinical trials that have seen a 93% remission rate.